Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)

Preventing relapse of myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) with steroids and immunosuppressants is sometimes difficult. There is no standard treatment for refractory cases. We present the case of a 17-year-old female patient with longitudinally extensive my...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Satomi Hiya, Hajime Yoshimura, Michi Kawamoto
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2023-06-01
Saila:	eNeurologicalSci
Gaiak:	Myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) Adolescent Neuromyelitis optica spectrum disorder (NMOSD) Multiple sclerosis (MS) Ofatumumab
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2405650223000199
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!